Trials / Sponsors / Immune System Key Ltd
Immune System Key Ltd
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML Advanced MDS, AML | Phase 1 | 2020-06-18 |
| Withdrawn | A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS Acute Myelogenous Leukemia, Myelodysplastic Syndromes | Phase 2 | 2018-10-25 |
| Withdrawn | Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Br Metastatic Ovarian Cancer, Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2018-09-06 |
| Completed | Phase 1 Trial of Intravenously Administered Nerofe™ in Subjects With Advanced Malignancies Cancer | Phase 1 | 2013-12-01 |